Reported Dec 26, 2018 · Terminated
Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India,…
Cipla Limited
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Cipla Limited · L129 - 146 S - 103 - 105 S - 107 - 112 L147 - L147/1/2/3 L147/A · Vasco Da Gama · N/A
Is this the product you have?
- Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only
- Manufactured byCipla Ltd. Verna Goa, India
- Manufactured for
Cipla USA Inc. 9100 S Dadeland BlvdSuite 1500 MiamiFL 33156NDC 69097-403-02
- Lot codes and dates
Lot #: GG80257Exp. 12/2019
- Amount recalled
- 4800 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Cipla Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.